Antidiabetics in chronic kidney disease: new questions to new and traditional drugs
Antidiabéticos en insuficiencia renal crónica: nuevas preguntas a nuevos y clásicos fármacos
Read
7625
Timeswas read the article
2464
Total PDF
5161
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 60 | 15 | 75 |
| 2025 5 | 91 | 108 | 199 |
| 2025 4 | 64 | 21 | 85 |
| 2025 3 | 79 | 57 | 136 |
| 2025 2 | 75 | 29 | 104 |
| 2025 1 | 63 | 24 | 87 |
| 2024 12 | 42 | 20 | 62 |
| 2024 11 | 50 | 58 | 108 |
| 2024 10 | 34 | 33 | 67 |
| 2024 9 | 48 | 27 | 75 |
| 2024 8 | 56 | 48 | 104 |
| 2024 7 | 40 | 33 | 73 |
| 2024 6 | 48 | 33 | 81 |
| 2024 5 | 54 | 30 | 84 |
| 2024 4 | 46 | 39 | 85 |
| 2024 3 | 36 | 29 | 65 |
| 2024 2 | 41 | 36 | 77 |
| 2024 1 | 40 | 23 | 63 |
| 2023 12 | 26 | 30 | 56 |
| 2023 11 | 44 | 27 | 71 |
| 2023 10 | 43 | 28 | 71 |
| 2023 9 | 45 | 37 | 82 |
| 2023 8 | 44 | 16 | 60 |
| 2023 7 | 38 | 42 | 80 |
| 2023 6 | 35 | 23 | 58 |
| 2023 5 | 47 | 34 | 81 |
| 2023 4 | 30 | 13 | 43 |
| 2023 3 | 46 | 17 | 63 |
| 2023 2 | 45 | 27 | 72 |
| 2023 1 | 47 | 25 | 72 |
| 2022 12 | 51 | 39 | 90 |
| 2022 11 | 46 | 34 | 80 |
| 2022 10 | 59 | 37 | 96 |
| 2022 9 | 37 | 32 | 69 |
| 2022 8 | 38 | 47 | 85 |
| 2022 7 | 28 | 41 | 69 |
| 2022 6 | 26 | 42 | 68 |
| 2022 5 | 31 | 29 | 60 |
| 2022 4 | 29 | 48 | 77 |
| 2022 3 | 34 | 58 | 92 |
| 2022 2 | 39 | 48 | 87 |
| 2022 1 | 47 | 29 | 76 |
| 2021 12 | 35 | 37 | 72 |
| 2021 11 | 34 | 33 | 67 |
| 2021 10 | 33 | 41 | 74 |
| 2021 9 | 21 | 32 | 53 |
| 2021 8 | 32 | 38 | 70 |
| 2021 7 | 17 | 29 | 46 |
| 2021 6 | 26 | 19 | 45 |
| 2021 5 | 37 | 34 | 71 |
| 2021 4 | 44 | 29 | 73 |
| 2021 3 | 55 | 34 | 89 |
| 2021 2 | 36 | 19 | 55 |
| 2021 1 | 24 | 16 | 40 |
| 2020 12 | 32 | 9 | 41 |
| 2020 11 | 18 | 12 | 30 |
| 2020 10 | 17 | 18 | 35 |
| 2020 9 | 16 | 7 | 23 |
| 2020 8 | 21 | 15 | 36 |
| 2020 7 | 27 | 10 | 37 |
| 2020 6 | 23 | 10 | 33 |
| 2020 5 | 31 | 13 | 44 |
| 2020 4 | 30 | 12 | 42 |
| 2020 3 | 21 | 8 | 29 |
| 2020 2 | 36 | 22 | 58 |
| 2020 1 | 31 | 19 | 50 |
| 2019 12 | 24 | 17 | 41 |
| 2019 11 | 19 | 10 | 29 |
| 2019 10 | 6 | 5 | 11 |
| 2019 9 | 19 | 23 | 42 |
| 2019 8 | 19 | 5 | 24 |
| 2019 7 | 15 | 20 | 35 |
| 2019 6 | 16 | 13 | 29 |
| 2019 5 | 10 | 14 | 24 |
| 2019 4 | 49 | 33 | 82 |
| 2019 3 | 22 | 19 | 41 |
| 2019 2 | 12 | 15 | 27 |
| 2019 1 | 22 | 16 | 38 |
| 2018 12 | 47 | 30 | 77 |
| 2018 11 | 57 | 17 | 74 |
| 2018 10 | 43 | 16 | 59 |
| 2018 9 | 41 | 10 | 51 |
| 2018 8 | 41 | 9 | 50 |
| 2018 7 | 29 | 8 | 37 |
| 2018 6 | 34 | 13 | 47 |
| 2018 5 | 23 | 12 | 35 |
| 2018 4 | 43 | 5 | 48 |
| 2018 3 | 27 | 9 | 36 |
| 2018 2 | 23 | 5 | 28 |
| 2018 1 | 40 | 9 | 49 |
| 2017 12 | 33 | 9 | 42 |
| 2017 11 | 31 | 7 | 38 |
| 2017 10 | 31 | 7 | 38 |
| 2017 9 | 27 | 14 | 41 |
| 2017 8 | 24 | 5 | 29 |
| 2017 7 | 28 | 13 | 41 |
| 2017 6 | 21 | 8 | 29 |
| 2017 5 | 37 | 11 | 48 |
| 2017 4 | 27 | 10 | 37 |
| 2017 3 | 23 | 9 | 32 |
| 2017 2 | 22 | 6 | 28 |
| 2017 1 | 16 | 10 | 26 |
| 2016 12 | 35 | 9 | 44 |
| 2016 11 | 36 | 6 | 42 |
| 2016 10 | 81 | 11 | 92 |
| 2016 9 | 50 | 2 | 52 |
| 2016 8 | 91 | 2 | 93 |
| 2016 7 | 136 | 10 | 146 |
| 2016 6 | 109 | 0 | 109 |
| 2016 5 | 115 | 0 | 115 |
| 2016 4 | 91 | 0 | 91 |
| 2016 3 | 84 | 0 | 84 |
| 2016 2 | 89 | 0 | 89 |
| 2016 1 | 79 | 0 | 79 |
| 2015 12 | 110 | 0 | 110 |
| 2015 11 | 84 | 0 | 84 |
| 2015 10 | 82 | 0 | 82 |
| 2015 9 | 41 | 0 | 41 |
| 2015 8 | 64 | 0 | 64 |
| 2015 7 | 73 | 0 | 73 |
| 2015 6 | 39 | 0 | 39 |
| 2015 5 | 41 | 0 | 41 |
| 2015 4 | 11 | 0 | 11 |
Show all
